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Aims Cardiac atrial natriuretic peptide (ANP) participates in the maintenance of arterial blood pressure and intravascular
volume homeostasis. The hypovolaemic effects of ANP result from coordinated actions in the kidney and systemic
microcirculation. Hence, ANP, via its guanylyl cyclase-A (GC-A) receptor and intracellular cyclic GMP as second mes-
senger, stimulates endothelial albumin permeability. Ultimately, this leads to a shift of plasma ﬂuid into interstitial
pools. Here we studied the role of caveolae-mediated transendothelial albumin transport in the hyperpermeability
effects of ANP.
Methods
and results
Intravital microscopy studies of the mouse cremaster microcirculation showed that ANP stimulates the extravasation
of ﬂuorescent albumin from post-capillary venules and causes arteriolar vasodilatation. The hyperpermeability
effect was prevented in mice with conditional, endothelial deletion of GC-A (EC GC-A KO) or with deleted
caveolin-1 (cav-1), the caveolae scaffold protein. In contrast, the vasodilating effect was preserved. Concomitantly,
the acute hypovolaemic action of ANP was abolished in EC GC-A KO and Cav-1
2/2 mice. In cultured microvascular
rat fat pad and mouse lung endothelial cells, ANP stimulated uptake and transendothelial transport of ﬂuorescent
albumin without altering endothelial electrical resistance. The stimulatory effect on albumin uptake was prevented
in GC-A- or cav-1-deﬁcient pulmonary endothelia. Finally, preparation of caveolin-enriched lipid rafts from mouse
lung and western blotting showed that GC-A and cGMP-dependent protein kinase I partly co-localize with Cav-1
in caveolae microdomains.
Conclusion ANP enhances transendothelial caveolae-mediated albumin transport via its GC-A receptor. This ANP-mediated
cross-talk between the heart and the microcirculation is critically involved in the regulation of intravascular volume.
-----------------------------------------------------------------------------------------------------------------------------------------------------------
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1. Introduction
Cardiac atrial natriuretic peptide (ANP) is an essential physiological,
endocrine regulator of arterial blood pressure and intravascular
volume.
1 It is secreted from atrial granules into the circulation in
response to acute or chronic atrial stretch to act as an antihyper-
tensive and antihypervolaemic factor via its guanylyl cyclase A
(GC-A) receptor and intracellular cyclic GMP as second
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1 Unlike other ‘natriuretics’ (such as furosemide), which
act via the kidneys to reduce interstitial and total body ﬂuid volume
with little change in plasma volume, the ANP/GC-A system has im-
portant extrarenal, endothelial actions that enable it to reduce
plasma volume preferentially.
2 The key mechanism, whereby ANP
causes the loss of ﬂuid from the intravascular space, is the increase
in endothelial permeability to plasma proteins such as albumin.
2 To
prove this concept in vivo, we have generated mice with conditional,
endothelium-speciﬁc deletion of GC-A (EC GC-A KO mice).
3 In
these mice, the vasodilating and renal actions of ANP are pre-
served. Yet, the selective ablation of the endothelial actions of
ANP resulted in signiﬁcant hypervolaemic hypertension, demon-
strating that concerted renal and endothelial actions of ANP are
essential for the maintenance of intravascular volume homeostasis.
3
However, the post-receptor pathways mediating the stimulation of
transvascular albumin transport by ANP are unknown.
Thetransportofplasmaproteinsandsolutesacrosstheendothelium
involves two different routes: one transcellular, via caveolae-mediated
vesiculartransport,andtheotherparacellular,viainterendothelialjunc-
tions.
4Inaddition,anintactglycocalyxispartoftheprimarybarrierthat
retains plasma proteins in the vascular space (reviewed by Curry and
Adamson).
5 All these pathways are exquisitely regulated in the resting
stateandinresponsetoextracellularstimuliandmediators.
4,5Unfortu-
nately, endothelial cells undergo signiﬁcant changes in phenotype in
cultureconditions.Forinstance,thedensityofcaveolaeortheorganiza-
tion of the glycocalyx, endothelial permeability components which
could be regulated by ANP, are remarkably different in cultured cells
compared with native endothelial cells.
5 Furthermore, cultured endo-
thelial cells, i.e. human umbilical vein endothelial cells, down-regulate
speciﬁcANP-modulatedsignallingpathways(suchascGMP-dependent
protein kinase I, cGKI)
6 or up-regulate others (such as the natriuretic
peptide clearance receptor). Based on these considerations, the
present study was designed mainly to test in vivo whether the ANP
stimulation of microvascular endothelial albumin permeability involves
caveolar transcytosis or paracellular transport pathways. In past
studies, we have used the two-tracer method to compare
125I-albumin blood-to-tissue clearances in different mouse tissues.
We observed that ANP primarily stimulates vascular permeability in
the skin and skeletal muscle.
3,7 These tissues may well serve as
dynamic reservoirs of small physiological amounts of intravascular
ﬂuid.Basedontheseobservations,inthepresentstudyweappliedintra-
vital microscopy to study directly the effects of ANP on the extravasa-
tionofﬂuorescentlylabelledalbuminfrompost-capillaryvenuleswithin
the cremaster muscle of mice. This approach enabled us to distinguish
between real increases in microvascular permeability and increased
clearance due to changes in microvascular perfusion, especially the
effect of an increased number of perfused microvessels after
ANP-induced vasodilatation. We used this technique to compare the
vasodilating and permeability effects of ANP in wild-type (WT) mice,
mice with endothelium-restricted deletion of GC-A,
3 and mice
lacking caveolae (Cav-1
2/2 mice).
8,9 These intravital microscopy
studies were combined with measurements of ANP-dependent
changes in plasma volume and with in vitro studies of albumin uptake
inWT,GC-A-orcaveolae-deﬁcientculturedmicrovascularendothelial
cells.Together, ourobservationsindicate thatthetransendothelial ves-
icular pathway participates in the stimulatory effects of ANP on the
albumin permeability of the microcirculation and subsequent changes
in plasma volume.
2. Methods
2.1 Genetic mouse models
MicewithselectivedeletionoftheANPreceptor,GC-A,inendothelialcells
(ECGC-AKOmice)weregeneratedandgenotypedaspreviouslydescribed
(Cre/loxP recombination system).
3 Studies were performed with ﬂoxed
GC-A mice (controls, which retain normal GC-A expression levels) and
ECGC-AKOlittermates(ﬂoxedGC-AmiceharbouringtheTie2-Cretrans-
gene, which drives the expression of Cre-recombinase in endothelia) in a
mixed genetic background (C57BL/6J/129SV). Caveolin-1-deﬁcient
(Cav-1
2/2) mice
8,9 and WT C57BL/6J littermates were from The Jackson
Laboratory. Two- to 3-month-old males were used in all studies. All
animal investigations conform to the Guide for the Careand Use of Laboratory
Animals published by the US National Institutes of Health (NIH publication
no. 85-23, revised 1996). Experiments were also approved by the animal
care committee of the University of Wu ¨rzburg (approval reference
number 54-2531.01-22/07).
2.2 Treatment with N-nitro-L-arginine
methyl ester
The Cav-1
2/2 and WT littermates were treated with the nitric oxide/
nitric oxide synthase (NOS) inhibitor N-nitro-L-arginine methyl ester
(L-NAME, 100 mg/kg/day; Sigma), via drinking water for 21 days.
10
2.3 Intravital microscopy: experimental set-up
and calculations
Mice were anaesthetized by an intraperitoneal injection of ketamine
(100 mg/kgbodyweight)andxylazine(10 mg/kg). Thedepth ofanaesthesia
was checked by ensuring that noxious pinch stimulation (blunt forceps) of
the hindpaw, the forepaw, and the ear did not evoke any motor reﬂexes.
Body temperaturewasmaintained at 378C. The cremaster musclewaspre-
pared for intravital microscopy on a custom-made stage and continuously
superfusedwithbicarbonate-bufferedsaline(pH7.4,348C)ofthefollowing
composition (mM): 138 Na
+,6K
+, 2.5 Ca
2+, 1.2 Mg
2+, 20 HCO3
–, 1.2
SO4
2–, and 1.2 H2PO4
–, at a rate of 1.2 mL/min.
11 Thereafter, the animals
were transferred onto a microscope stage (Olympus, Hamburg,
Germany). At the end of the experiment, the mice were euthanized via
intravenous ketamine injection.
To assess microvascular permeability of macromolecules, ﬂuorescein
isothiocyanate (FITC)-labelled bovine serum albumin (BSA) or FITC–
dextran (MW 150000; both from Sigma) were dissolved in phosphate-
buffered saline at a concentration of 10 mg/mL. The free ﬂuorescent
dye in the solution was removed by passing through a size exclusion
column. After tail vein injection of 0.1 mL FITC–BSA or FITC–dextran,
intravital ﬂuorescence microscopy was performed using a ﬂuorescence
ﬁlter for FITC for epi-illumination. The microscopic images were recorded
by a charge-coupled device camera and transferred to a computer system
for off-line evaluation. Topical application of ANP (100 nM; Bachem, Weil
am Rhein, Germany) or vehicle was always started 10 min after i.v. admin-
istration of FITC–BSA or FITC–dextran and continued for 30 min. Sub-
sequently, histamine (10 mM; Sigma) was superfused for 10 min.
To block caveolae/lipid rafts and thereby transcellular vesicle transport,
1 mM methyl-b-cyclodextrin (MbCD; Sigma) was added to the superfu-
sate.
12 The cremaster muscle was pre-incubated for 15 min, followed by
vehicle or ANP superfusion as described above.
Quantitative off-line analysis of the microscopic images was performed
with the computer-assisted image analysis system Cell-D (Olympus). The
observer was blinded to the treatment and genotype. Changes in micro-
vascular permeability were measured using integrated optical intensity
(IOI) as an index.
13 Six interstitial areas, immediately adjacent to post-
capillary venules, were randomly selected for IOI analysis. The same pre-
selected areas were observed every 10 min.
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topically applied ANP. Measurements were made on pre-capillary arter-
ioles with a diameter of  25 mm. Only one vessel was studied in each
animal. Diameters represent the average of ﬁve measurements taken at
ﬁve locations on each vessel at the same time.
14 Effects of ANP were nor-
malized by expressing data as a percentage of the maximal vasodilatation
evoked by topical application of 30 mM sodium nitroprusside (SNP;
Sigma) at the end of the experiment.
14
2.4 Culture of microvascular endothelial cells
and cGMP determinations
We performed our in vitro studies with two types of microvascular endo-
thelial cells. Rat fad pad endothelial cells (RFPECs; a kind gift from Dr Arie
Horowitz, Dartmouth Medical School, Lebanon, NH, USA)
15 were cul-
tured in Dulbecco’s modiﬁed Eagle’s medium containing 10% fetal calf
serum.
15 Endothelial cells from peripheral lung tissue of GC-A- or Cav-1-
deﬁcient and respective control mice (MLECs; murine lung endothelial
cells) were isolated and cultured as previously described.
16 We recently
reported that RFPECs and WT MLECs express the GC-A receptor and
the cGMP-modulated kinase (cGKI).
16 All experiments with RFPECs and
MLECs were conducted in mitogen-free, serum-reduced Dulbecco’s
modiﬁed Eagle’s medium (0.5% fetal calf serum during 3 h prior to experi-
mentation). The cGMP contents were quantiﬁed by radio-immunoassay.
16
2.5 Determination of ﬂuorescent albumin
uptake
Conﬂuent RFPECs and MLECs on glass coverslips were treated with
ﬂuorescently tagged albumin (Alexa Fluor 488-labelled BSA; Invitrogen)
at 10 mg/mL, plus 0.5 mg/mL unlabelled albumin in phosphate-buffered
saline and vehicle or ANP for 30 min.
17 MbCD was used to disrupt caveo-
lae (2 mM, 15 min pre-treatment).
17 Unincorporated probe was removed
by rinsing in phosphate-buffered saline. Internalized ﬂuorescent albumin
was viewed by confocal microscopy in optical sections mid-way through
the cell. Cell nuclei were labelled with 4′,6-diamidino-2-phenyl indole
dihydrochloride (DAPI; Thermo Scientiﬁc, Dreieich, Germany).
17 Brieﬂy,
the monolayer cultures were rinsed and ﬁxed with 4% paraformaldehyde
in phosphate-buffered saline; DAPI (1 mg/mL) was added immediately
after cell ﬁxation for 10 min. The cells were washed three times with
phosphate-buffered saline, and ﬁnally mounted on glass slides using
Mowiol mounting medium (Sigma). Confocal images were acquired with
a laser-scanning confocal microscope (Leica TCS SP5) using diode
pumped solid-state UV laser and argon excitation laser line for Alexa 488.
2.6 Permeability assay on permeable supports
RFPECs (100 000 cells per insert) were grown to conﬂuence on gelatin-
coated polystyrene ﬁlters (Costar Transwell distributed by Corning,
Wiesbaden, Germany) in six-well plates over 5 days. After cells were
equilibrated in medium with 0.5% fetal calf serum during 3 h, 50 mM
FITC–BSA suspended in 100 mL serum-free medium was added to the
apical surface. Ten minutes later, 100 nM ANP or 0.125 U/mL thrombin
was added apically. FITC–BSA in the basolateral compartment was mea-
sured with a ﬂuorescence spectroﬂuorophotometer after 1, 30, and
60 min. The concentrations were calculated based on standard solutions
of FITC–BSA in serum-free medium.
2.7 Transendothelial electrical resistance
Transendothelial electrical resistance was recorded using the electrical
impedance system (ECIS 1600R; Applied BioPhysics distributed by Ibidi
GmbH, Martinsried, Germany). RFPECs were grown to conﬂuence on
gelatine-coated gold microelectrodes. For the experiments, cells were
allowed to equilibrate for  2 h and then either 100 nM ANP or
0.125 U/mL thrombin was added. The effects on transendothelial electric-
al resistance were recorded during an additional 4 h.
2.8 Preparation of caveolin-enriched lipid raft
fractions and western blotting
Freshly isolated mouse lungs were lysed in 2 mL of ice-cold 1% Triton
X-100/Mes-buffered saline (MBS) (Mes hydrate 25 mM, pH 6.5, NaCl
0.15 M, and protease inhibitor cocktail) on ice for 1 h.
18 Homogenization
was carried out sequentially with a Dounce (Qiagen GmbH, Hilden,
Germany) homogenizer (10 strokes), a Polytron (Qiagen GmbH) tissue
grinder (three 10 s bursts), and a sonicator (three 20 s bursts). Lysates
were mixed with an equal volume of 80% sucrose in MBS (without
Triton X-100) and transferred to 14 mm × 89 mm Beckman centrifuge
tubes. Three and a half millilitres of 35% sucrose in MBS was layered care-
fully on the top of the mixture, followed by another 3.5 mL layer of 5%
sucrose. Then the sucrose gradient was centrifuged in a SW 41 rotor
(Beckman Coulter GmbH, Krefeld, Germany) at 200000 g for 18 h at
48C. Twelve 1 mL fractions were collected from the top to the bottom
of the tube. A light-scattering band at the 5–35% sucrose interface was
observed that contained caveolae (fraction 5). Aliquots of all fractions
were mixed with Laemmli buffer, denatured at 958C, and separated by
12% SDS–PAGE. Electrophoresis and immunoblotting were performed
as previously described.
16 Antibodies were against GC-A,
16 Cav-1, and
cGKI (Cell Signaling Technology, Frankfurt am Main, Germany).
2.9 Acute effects of exogenous ANP
on haematocrit
Anaesthetized EC GC-A KO and Cav-1
2/2 mice and respective control
littermates received ANP (500 ng/kg/min, 2.5 mL/kg/h) through a jugular
catheter via a microinfusion pump.
3 Haematocrit was measured before
and at 30 min of infusion. The conditions of anaesthesia, control of anaes-
thesia, and method of euthanasia as described for intravital microscopy
experiments.
2.10 Statistics
Results are presented as the means+SEM. Comparisons within groups
were performed using ANOVA and Wilcoxon matched pairs test. Data
between groups were compared by ANOVA followed by non-parametric
Mann–Whitney U test, with P , 0.05 considered signiﬁcant.
3. Results
3.1 ANP enhances endothelial albumin
permeability of the cremaster
microcirculation via the endothelial
GC-A receptor
Our ﬁrst series of in vivo experiments aimed to study the vasodilating
and permeability effects of ANP in the microcirculation of the mouse
cremaster. As shown in Figure 1A, topical application of ANP (100 nM)
induced a rapid increase in diameter of pre-capillary arterioles, which
amounted to 36+4% of maximal dilatation caused by SNP. This
vasodilating effect of ANP was not different in control and EC
GC-A KO mice. In a separate series of experiments, we studied
effects of ANP on FITC–BSA extravasation from post-capillary
venules (20–40 mm diameter). As shown in Figure 1B, only very
subtle increases in interstitial ﬂuorescence intensity were observed
during the 30 min superfusion of the cremaster preparation with
bicarbonate-buffered saline (vehicle), indicating that the basal leaki-
ness of the microvasculature to albumin was very low. In control
mice, topical application of ANP (continuous superfusion with
100 nM ANP, 30 min) led to a mild, progressive increase in interstitial
ﬂuorescence intensity, indicating signiﬁcantly increased microvascular
permeability to albumin (Figure 1B). On average, baseline interstitial
ANP and endothelial permeability 143ﬂuorescence (IOI) was enhanced by 4.6+0.7-fold at 30 min of ANP
superfusion. In EC GC-A KO mice, the stimulatory effect of ANP on
FITC–BSA extravasation was abolished (Figure 1C). The inﬂammatory
stimulus, histamine (10 mM, superfused for 10 min after vehicle or
ANP), provoked immediate, drastic increases in FITC–BSA extravasa-
tion which did not differ between control and EC GC-A KO litter-
mates. At 5 min of histamine superfusion, IOI was increased by
7.5+0.6- vs. 6.9+1.1-fold [in arbitrary units: control mice, 0.07+
0.01 (baseline) and 0.52+0.05 (histamine; P , 0.05 vs. ANP); EC
GC-A KO mice, 0.09+0.01 (baseline) and 0.62+0.05 (histamine;
P , 0.05 vs. ANP)]. At 10 min of continuous histamine superfusion,
the effect was slightly reversed (increases in baseline interstitial ﬂuor-
escence of 6.5+0.7- vs. 5.8+0.8-fold in control and KO mice, re-
spectively). The effects of histamine were similar in vehicle-
compared with ANP-treated control tissues (increases in interstitial
ﬂuorescence of 7.5+0.6- vs. 8.1+0.1-fold in vehicle vs.
ANP-superfused control mice).
Next we tested in control mice the effects of ANP on microvascu-
lar permeability for dextran, another high-molecular mass agent. As
demonstrated in Figure 2, ANP (100 nM, superfused for 40 min) did
not enhance FITC–dextran extravasation. In contrast, histamine
(10 mM, superfused for 10 min) provoked marked increases in inter-
stitial deposition of FITC–dextran both after vehicle and after ANP
superfusion (by 6.8+1.9- vs. 6.4+1.6-fold, respectively; Figure 2).
We conclude that ANP, via its endothelial GC-A receptor,
increases the transvascular transport of albumin between the blood
and interstitial compartment of the cremaster muscle. This permeabil-
ity effect is independent from the vasodilating action of ANP, is select-
ive for albumin, and is milder than the effect of the inﬂammatory
stimulus, histamine.
Figure 1 Endothelium-restricted disruption of GC-A preserves the vasodilating but prevents the permeability actions of ANP in the mouse cre-
master microcirculation. (A) Effect of ANP (100 nM) and SNP (30 mM) on arteriolar diameters in control and EC GC-A KO mice. Left, absolute
changes in vessel diameter; right, the effect of ANP is expressed as a percentage of the maximal vasodilatation evoked by subsequent topical appli-
cation of SNP. (B and C) Time course of changes in net integrated optical intensity (IOI; an index of permeability) during 30 min of continuous local
ANP (100 nM) or vehicle superfusion in control mice (B) and in mice with conditional, endothelial GC-A deletion (EC GC-A KO; C; n ¼ 6 mice per
genotype and treatment; *P , 0.05 vs. vehicle). As shown in the original photographs, the hyperpermeability effects of histamine are much greater
than the effects of ANP.
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and transcytosis in cultured RFPECs
To differenciate between paracellular and transcellular pathways of
albumin transport in vitro, the permeability responses to ANP were
studied in spontaneously immortalized, well-characterized cultured
microvascular endothelial cells from rat epididymal fat pad capillaries
(RFPECs).
15 As shown in Figure 3A, ANP (10 min incubation) markedly
increased the intracellular cGMP content of RFPECs in a
concentration-dependent manner, demonstrating expression of the
GC-A receptor. We ﬁrst addressed the possibility that ANP/GC-A
activation stimulates endocytosis of albumin, the initial step in
albumin transport via transcytosis.
17 As shown in Figure 3B, ﬂuores-
cence, quantiﬁed as pixel intensity per cell using confocal microscopy,
showed that ANP (10 and 100 nM, 30 min) signiﬁcantly increased
Alexa 488–albumin uptake by RFPECs. Disruption of caveolae by pre-
treatment with methyl-b-cyclodextrin (2 mM MbCD for 15 min)
17
prevented the ANP-dependent increase in albumin uptake
(Figure 3B). Paralleling these responses, ANP enhanced transendothe-
lial, apical-to-basolateral transport of FITC–BSA by RFPECs seeded
on permeable ﬁlters (Figure 3C). To determine whether increased
transendothelial albumin ﬂux was the result of opening of interen-
dothelial junctions, we measured changes in transendothelial electrical
resistance. Incubation of RFPECs with 100 nM ANP did not alter
transendothelial electrical resistance (Figure 3D), indicating preservation
of paracellular junctions. In comparison, thrombin (0.125 U/mL),
which is known to impair the endothelial barrier severely, led to a
marked increase in transendothelial FITC–albumin ﬂux (Figure 3C)
and decreased transendothelial electrical resistance by 80% from
baseline (Figure 3D). Together, these data indicate that ANP stimulates
endocytosis and transcellular transport of albumin by RFPECs. In con-
trast to thrombin, this occurs without marked opening of interen-
dothelial junctions.
3.3 ANP stimulates caveolae-dependent
albumin endocytosis in MLECs
To further investigate whether intact caveolae are required for
ANP/GC-A/cGMP-stimulated endothelial albumin endocytosis, we
performed experiments with primary cultured microvascular lung
endothelial cells (MLECs) isolated from WT, GC-A- or Cav-1-
deﬁcient (Cav-1
2/2) mice. Studies in Cav-1
2/2 mice have
demonstrated the absence of endothelial caveolae and defective
transcellular transport of albumin.
8,9 As shown in Figure 4A, ANP
(10 min incubation) markedly increased intracellular cGMP
content in WT MLECs in a concentration-dependent manner.
These cGMP responses to ANP were abolished in GC-A-deﬁcient
MLECs, but were only slightly and not signiﬁcantly attenuated in
Cav-1-deﬁcient MLECs. At the maximal concentration tested,
ANP (1 mM) increased basal cGMP content by 14+3-fold in
WT and by 8+1.2-fold in Cav-1-deﬁcient MLECs. Fluorescence,
quantiﬁed as pixel intensity per cell using confocal microscopy,
showed that ANP (10 and 100 nM) induced signiﬁcant increases
in Alexa 488–albumin uptake by WT MLECs (Figure 5A). Again,
pre-treatment with MbCD (2 mM for 15 min)
17 prevented the
ANP-dependent increase in albumin uptake (Figure 5A). Further-
more, these stimulatory effects on albumin endocytosis were abol-
ished in GC-A-deﬁcient (Figure 5B) or Cav-1-deﬁcient MLECs
(Figure 5C), corroborating the notion that intact caveolae were
required for this endothelial response to ANP/GC-A stimulation.
Unfortunately, we could not complement these uptake studies
with studies of transendothelial albumin transport. MLECs cultured
on permeable supports exhibited a high baseline transendothelial
leackage of FITC–BSA, which was not further stimulated by ANP
or thrombin.
3.4 The GC-A receptor and its downstream
signalling protein, cGKI, are localized in
caveolae
To study whether the GC-A receptor is located in caveolae microdo-
mains, Cav-1-rich lipid rafts were puriﬁed from murine peripheral lung
tissue. As shown in Figure 4B, western blotting of membrane fractions
demonstrated that a subpopulation of GC-A receptors is indeed
located in caveolae, together with Cav-1 as the signature protein of
endothelial caveolae (in fraction 5).
8,9 However, a signiﬁcant amount
of GC-A was also detected in other fractions (fractions 8–12). The
same distribution was observed for cGKI, a downstream target of
GC-A/cGMP.
3.5 Microvascular permeability responses
to ANP are abolished in Cav-1
2/2
mice or by topical superfusion
of methyl-b-cyclodextrin
We used Cav-1
2/2 mice to study whether caveolae are involved in
the acute effects of ANP on microvascular albumin permeability and
Figure 2 ANP, in contrast to histamine, does not stimulate the
extravasation of FITC–dextran within the cremaster microcircula-
tion. Net IOI (an index of permeability) was evaluated during
40 min of continuous local vehicle (saline) or ANP (100 nM) super-
fusion. Thereafter, histamine (10 mM) was superfused for an add-
itional 10 min (n ¼ 5 mice per treatment; *P , 0.05 vs. vehicle).
ANP and endothelial permeability 145intravascular ﬂuid volume. Several groups have shown that, despite
the loss of endothelial caveolae, Cav-1
2/2 mice show marked
increases in microvascular paracellular albumin permeability, which
is partly due to constitutive activation of endothelial NOS.
19 Treat-
ment with L-NAME (a well-established NOS inhibitor) rescued the
microvascular hyperpermeability phenotype of Cav-1
2/2 mice.
19
Hence, to reverse basal paracellular hyperpermeability and to
examine whether absence of caveolae alters the microcirculatory per-
meability effects of ANP, Cav-1
2/2 and respective WT mice were
treated with L-NAME (100 mg/kg/day, 3 weeks) prior to all experi-
ments. As shown in Figure 6A, topical application of ANP (100 nM)
once more induced a rapid increase in diameter of pre-capillary arter-
ioles, which amounted to 44+7% of the maximal dilatation caused
by SNP. This vasodilating effect of ANP was not different in WT
and Cav-1
2/2 mice. In WT mice, topical superfusion of the cremaster
muscle with ANP (100 nM, 30 min) signiﬁcantly stimulated FITC–BSA
extravasation (Figure 6B). In Cav-1
2/2 mice, the basal extravasation of
FITC–BSA (during saline superfusion) was slightly higher compared
with WT mice (Figure 6C); however, the permeability responses to
ANP were completely abolished (Figure 6C). Note that the rate of
FITC–BSA extravasation during ANP superfusion was even lower,
as observed during vehicle superfusion. The effects of histamine
(10 mM, 10 min) were similar in WT and Cav-1
2/2 mice (6.6+0.9-
and 6.2+1.2-fold increases in baseline interstitial ﬂuorescence) and
again were not altered by ANP pre-treatment.
To block caveolae/lipid rafts and thereby transcellular vesicle trans-
port in an acute fashion, in a separate series of experiments with WT
mice 1 mM MbCD was added to the superfusate. The cremaster
muscle was pre-incubated for 15 min, followed by vehicle or ANP
treatment.
12 Unexpectedly, topical application of MbCD itself
resulted in signiﬁcantly increased baseline vascular permeability. As
depicted in Supplementary material online, Figure S1, signiﬁcant
increases in interstitial ﬂuorescence intensity were observed during
the 30 min superfusion of the cremaster preparation with vehicle
(after MbCD). ANP had no additional effect on FITC–BSA extravasa-
tion (see Supplementary material online, Figure S1). In fact, the rate of
Figure 3 ANP increases cGMP content and stimulates endocytosis and transcellular transport of albumin in microvascular rat fat pad endothelial
cells (RFPECs). Effect of ANP on cyclic GMP content (A), uptake of Alexa 488-labelled albumin (B), transendothelial FITC–BSA permeability (C), and
TER (D). In (B), ANP effects were abolished after pre-treatment of RFPECs with MbCD (2 mM, 15 min). In (C and D), thrombin was used for com-
parison. (B) Confocal images showing ANP-induced concentration-dependent increases in the uptake of Alexa 488-labelled albumin (green). The
nucleus (blue) was stained with DAPI. Results are typical of three to four experiments. *P , 0.05 compared with vehicle.
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observed during vehicle superfusion.
3.6 The acute hypovolaemic responses
to ANP are abolished in EC GC-A KO
and Cav-1
2/2 mice
Finally, to study the contribution of endothelial caveolae-mediated
albumin transcytosis to the acute hypovolaemic action of ANP,
we tested the effect of intravenous ANP administration (500 ng/
kg/min, 30 min) on haematocrit. Many previous studies have
demonstrated that changes in this parameter in response to ANP
reﬂect acute changes in intravascular ﬂuid volume.
3,20 First, we
studied the responses of EC GC-A KO mice and littermate
control animals. Infusion of ANP in control mice caused a signiﬁ-
cant increase in haematocrit by 14+0.6% (n ¼ 6; P , 0.05).
Taking the average plasma volume of a 30 g mouse as 1530 mL,
3,7
the increase in haematocrit after ANP corresponded to a mean
loss of 198 mL ﬂuid from the intravascular to the interstitial
space. Similar effects of ANP have been reported in many other
studies.
3,7,20 Infusion of ANP failed to increase, and surprisingly,
even diminished haematocrit in EC GC-A KO mice by 5.4+0.7%
from baseline (n ¼ 6; P , 0.05), suggesting a paradoxical hypervo-
laemic effect.
Figure 4 Murine microvascular lung endothelial cells (MLECs) express GC-A receptors, a subpopulation being present in caveolin-enriched lipid
rafts. (A) Effect of ANP on intracellular cyclic GMP content. ANP increases cGMP in WT but not in GC-A-deﬁcient MLECs. In Cav-1-deﬁcient MLECs,
the maximal cGMP responses are slightly but not signiﬁcantly diminished. (B) Peripheral lung tissues were homogenized and subfractionated to isolate
light buoyant density membranes (rafts). Western blotting demonstrates the localization of GC-A and cGKI in caveolin-enriched lipid rafts (fraction 5).
Immunoblots are representative of three separate experiments.
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of ANP involves caveolae, we studied haematocrit responses in
Cav-1
2/2 and respective WT mice, both pre-treated with L-NAME.
Infusion of ANP evoked signiﬁcant increases in haematocrit of WT
mice (by 14.2+1%; n ¼ 5, P , 0.05). In contrast, ANP infusion had
no effect on haematocrit of Cav-1
2/2 mice (n ¼ 5).
4. Discussion
The experiments reported made use of EC GC-A KO and Cav-1
2/2
mice to investigate the role of endothelial caveolae in the stimulation
of physiological permeability by ANP. Intravital microscopy studies of
the cremaster muscle microcirculation showed that ANP causes vaso-
dilatation and enhances albumin extravasation. Notably, despite full
preservation of the direct vasodilating effect of ANP, the stimulatory
effect of ANP on albumin permeability was abolished in EC GC-A KO
mice. This permeability effect of ANP is selective for albumin, but not
for dextran. It involves endothelial caveolae, because it was absent in
mice lacking caveolae (Cav-1
2/2 mice). Concomitantly, the acute
hypovolaemic effects of the hormone were inhibited in EC GC-A
KO and Cav-1
2/2 mice. In vitro, ANP stimulated albumin uptake in
cultured microvascular rat fat pad and mouse lung endothelia in a
GC-A- and Cav-1-dependent manner. Finally, enrichment of caveolae
from mouse lungs together with western blot analyses demonstrated
that a population of GC-A receptors co-localizes with Cav-1 in caveo-
lae microdomains. Taken together, these data suggest a critical role
for caveolae in the ANP-induced mild endothelial hyperpermeability
of the systemic microcirculation.
Figure 5 ANP, via GC-A, stimulates caveolae-mediated albumin endocytosis in MLECs. (A) Left, confocal images showing the uptake of Alexa
488-labelled albumin (green). The nucleus (blue) was stained with DAPI. Right, ﬂuorescence, quantiﬁed as pixel intensity per cell using confocal mi-
croscopy, showed that ANP induced concentration-dependent increases in Alexa 488-albumin uptake by WT MLECs. These responses were abol-
ished after pre-treatment of WT MLECs with MbCD (2 mM, 15 min; A) as well as in GC-A-deﬁcient (B) or in Cav-1-deﬁcient MLECs (C). For each
genotype, n ¼ 3–4. *P , 0.05 compared with vehicle.
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2/2 mice have contributed a lot to the understanding of
caveolin and caveolae; however, these mice exhibit many chronic vas-
cular alterations, such as pathological angiogenesis and paracellular
hyperpermeability.
8,19,21 Therefore, we wanted to conﬁrm our obser-
vations in this genetic model by a pharmacological approach. To block
acutely the caveolae/lipid rafts and thereby transcellular vesicle trans-
port in the mouse microcirculation, the cremaster muscle was locally
pre-treated with MbCD.
12 Unexpectedly, after MbCD treatment the
baseline albumin extravasation from post-capillary venules was signiﬁ-
cantly enhanced. ANP treatment, in contrast, had no visible additional
effect on microvascular permeability. These results suggest that block-
ade of caveolae with MbCD inhibits ANP-induced transcytosis, but
may itself activate paracellular transport mechanisms, as recognized
in Cav-1
2/2 mice.
19,21 For instance, in cultured epithelial cells, deple-
tion of cell cholesterol with MbCD altered tight junction integrity
through the displacement of key junctional proteins (claudins and
occludin).
22 Hence, despite all their limitations, Cav-1
2/2 mice prob-
ably represent the best approach to study the role of transendothelial
vesicular transport in vivo.
Intravital microscopy revealed a decreased number of microvessels
in the cremaster muscle of Cav-1
2/2 compared with WT mice, which
is consistant with published studies.
21 However, this anatomical alter-
ation should not inﬂuence the results of our in vivo experiments with
ANP, because we quantiﬁed the ANP effects on permeability of single
post-capillary venules via ﬂuorescence recordings of interstitial areas
immediately adjacent to them.
As caveolae microdomains provide a spatially preferable environ-
ment for a variety of receptors, channels, and enzyme systems,
23
we studied whether GC-A is present in this plasma membrane com-
partment of endothelia, as has been shown for cardiac myocytes.
24
We used peripheral lung tissue to prepare membrane rafts, because
our previous studies showed that in this tissue the microvascular
endothelial cells are the main source of GC-A. We found that a popu-
lation of GC-A receptors is indeed located in Cav-1-containing endo-
thelial rafts, suggesting that ANP stimulates caveolae-mediated
transcytosis via local GC-A/cGMP signalling; however, a large
amount of GC-A protein was also detected in other membrane frac-
tions, outside membrane rafts. Moreover, cGMP responses of
Figure 6 The microvascular hyperpermeability effects of ANP are abolished in Cav-1-deﬁcient mice, while the vasodilatating effects are preserved.
(A) Effect of ANP (100 nM) and SNP (30 mM) on arteriolar diameters in control and Cav-1
2/2 mice. Left, absolute changes in vessel diameter; right,
the effect of ANP is expressed as a percentage of the maximal vasodilatation evoked by subsequent topical application of SNP. (B and C) Time course
of changes in net IOI during 30 min of continuous local ANP (100 nM) or vehicle superfusion. (B) ANP increases FITC–BSA extravasation in control
mice. (C) The permeability responses to ANP are abolished in mice with deleted Cav-1 (n ¼ 8 mice per genotype and treatment; *P , 0.05 vs. vehicle).
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ated slightly, conﬁrming that a major population of endothelial GC-A
receptors is located in other membrane compartments, outside
caveolae. This receptor population might mediate other endothelial
responses to ANP, such as proliferation and migration,
16 or it may
also participate in the regulation of endothelial permeability.
The cellular pathways that link the activation of endothelial GC-A/
cGMP to the stimulation of transcellular caveolae-mediated albumin
transport remain unknown. Caveolin-1 is the main structural compo-
nent of endothelial caveolae and regulates endothelial transcytosis.
25
Many molecular aspects of Cav-1-regulated ﬁssion and trafﬁcking of
caveolae remain unclear. It was shown that Src kinase-mediated phos-
phorylation of Cav-1 on tyrosine 14 stimulates caveolar ﬁssion.
25
However, our in vitro experiments demonstrated that the levels of
Tyr14-phosphorylated Cav-1 following treatment of RFPECs and
MLECs with ANP were not changed (immunoblotting; data not
shown), suggesting the existence of an independent pathway.
In cultured human fetal macrovascular endothelia (human umbilical
vein endothelial cells), ANP/GC-A-mediated cGMP production stimu-
lates phosphodiesterase 2 and thereby lowers cAMP content.
26 As
cAMP regulates the stability of intercellular junctions via the Epac/
Rap/Rac pathway,
4,26 a decrease in cAMP by ANP could increase para-
cellular permeability. Other possible actions of GC-A/cGMP are the
cGKI-mediated phosphorylation of vasodilator-stimulated phospho-
protein, a protein associated with focal adhesion sites and adherens
junctions, as well as modiﬁcations of the glycocalyx.
6,27 Although
the functional relevance of these ANP/GC-A/cGMP-driven signalling
pathways in the microvascular systemic endothelium in vivo has not
been demonstrated, we cannot rule out the possibility that ANP mod-
ulates additional endothelial components contributing to the
observed increases in microcirculatory permeability.
Beyondthephysiologicalmildpermeability-increasing(volume-regu-
lating) effects on quiescent endothelial cells, ANP has been shown to
exertbarrier-protectingactionsonaninﬂammation-activatedendothe-
lium. The peptide lowered endothelial stress ﬁbre formation and para-
cellular leakage in vitro induced by pro-inﬂammatory stimuli, such as by
hypoxia,
28 lipopolysaccharide,
29 tumour necrosis factor-a, or hista-
mine.
30 Up to now, a single study has validated these observations in
vivo, demonstrating that exogenous ANP attenuates histamine-induced
microvascular FITC–dextran extravasation in rats.
30 In contrast, our
intravital microscopy studies did not reveal antagonistic actions of
ANP on inﬂammatory effects of histamine in the mouse cremaster
microcirculation.However,asourstudywasnotdirectedtostudypos-
sibleanti-inﬂammatoryeffectsofANP,wetestedonlyasingle,veryhigh
histamineconcentration.Ultimately,thequestionofwhetherandwhen
endogenous ANP plays an important pathophysiological role in
strengthening the endothelial barrier in inﬂammatory conditions in
vivo needs further investigation.
Together with previously published studies,
2,3,7,20 our observations
corroborate the notion that concerted renal and endothelial effects of
ANP co-operate in the regulation of intravascular volume. To under-
stand this concept, it is important to distinguish the action of a diuretic
drug, such as furosemide, from the action of ANP. Trippodo and
Barbee demonstrated that the extracellular ﬂuid excreted by the
kidney in response to furosemide comes mainly from the interstitial
space.
31 In contrast, more than half of the ﬂuid excreted by the
kidney in response to ANP comes from the intravascular space.
31
The reason for this difference is that ﬂuid loss, initially from the vas-
cular space during renal water excretion, concentrates the plasma
proteins in the vascular space. With furosemide there is no increase
in vascular permeability, and the elevated plasma protein oncotic
pressure leads to exchanges in ﬂuid from the interstitial space into
the vascular space (because the Starling forces governing transvascular
ﬂuid exchange shift towards net reabsorption as the plasma protein
concentration increases). In this way, signiﬁcant amounts of ﬂuid can
be excreted from the interstitial space by ﬁrst being reabsorbed
into the vascular space from the interstitium and then excreted.
This mode of action explains why loop diuretics can be efﬁciently
used for the treatment of oedema. In contrast, as demonstrated
here, ANP increases microvascular transendothelial albumin transport
at the same time as the diuresis is occuring. There is a shift of the con-
centrated plasma protein from the vascular to the interstitial space,
mainly in skin and skeletal muscle,
7 reduced rate of plasma protein
concentration, reduced reabsorption from the extravascular space
and preferential loss of ﬂuid from the intravascular space. These
co-ordinated renal and endothelial actions of ANP are essential to
the chronic maintenance of intravascular volume homeostasis, but
also explain the acute hypovolaemic actions of this cardiac hormone.
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